首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >Open-Access LC/MS/MS Platform for Rapid Bioanalysis in Drug Discovery
【24h】

Open-Access LC/MS/MS Platform for Rapid Bioanalysis in Drug Discovery

机译:用于药物发现中快速生物分析的开放式LC / MS / MS平台

获取原文

摘要

There are numerous types of in vitro ADME assays conducted in lead optimization phases of small molecule drug discovery. Nearly all of these assays use LC/MS/MS for bioanalytical quantification. The myriad of assays and formats can make communication around sample handoff between bioassay and bioanalytical scientist time consuming and prone to error. With the additional advancements in automation described here we have been able to improve productivity associated with the sample analysis. The open-access approach allows both bioanalytical and bioassay scientist to treat ADDA-OAR workstation as an appliance and/or plate-reader style measurement device and proficiently run routine samples. This approach has further shown resource efficiency as it allows bioanalytical personnel time to develop difficult or specialty LC/MS/MS methods, thereby accelerating project progression overall.
机译:在小分子药物发现的铅优化阶段进行了许多类型的体外Adme测定。几乎所有这些测定使用LC / MS / MS进行生物分析量化。无数的测定和格式可以在生物测定和生物分析科学家之间消耗和易于错误之间的样品切换进行沟通。随着这里描述的自动化的额外进步,我们已经能够提高与样本分析相关的生产率。开放式接入方法允许生物分析和生物测定科学家将ADDA-OAR工作站视为设备和/或板读者样式测量装置,熟练地运行常规样本。这种方法进一步示出了资源效率,因为它允许生物分析人员时间开发困难或专业LC / MS / MS方法,从而整体地加速项目进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号